Title:
卵巣がんおよびその他のがんに対する免疫療法において使用するための新規ペプチドおよびペプチド組み合わせ
Document Type and Number:
Japanese Patent JP7337695
Kind Code:
B2
Abstract:
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Inventors:
Schuster, Heiko
Pepel, Janet
Louvre, kevin
Wagner, filip
Rammensee, Hans-Georg
Pepel, Janet
Louvre, kevin
Wagner, filip
Rammensee, Hans-Georg
Application Number:
JP2019539937A
Publication Date:
September 04, 2023
Filing Date:
January 26, 2018
Export Citation:
Assignee:
Immatics Biotechnology Gem Beher
International Classes:
C12N15/13; A61K31/7088; A61K35/15; A61K35/17; A61K38/08; A61K39/395; A61K47/50; A61K48/00; A61P35/00; A61P35/02; C07K14/725; C07K14/74; C07K16/28; C12N5/0783; C12N5/0784; C12N15/115; C12N15/63; C12P21/08; G01N33/53
Foreign References:
| WO2017009400A1 |
Other References:
Proceedings of the National Academy of Sciences of the United States of America,2010年11月02日,Vol. 107, No. 44,p. 18769-18776,doi:10.1073/pnas.1008501107
Attorney, Agent or Firm:
Takashi Shoji
Yuriko Sukenobu
Takuya Osugi
Hirata Midori
Yuriko Sukenobu
Takuya Osugi
Hirata Midori